INTRODUCTION AND OBJECTIVES: The American Joint
Committee on Cancer defines T1 bladder cancer as the invasion of tumor cells into the lamina propria (LP), yet pathologists often struggle to confirm LP and/or muscularis mucosae invasion using H&E stains from bladder biopsies. Accurate reporting of the depth of LP invasion is important because of the worsened clinical outcomes observed in patients with deep invasion. We present an automated image analysis method that can recognize urothelium (U), LP, and muscularis propria (MP) from digital images of H&E-stained slides of bladder tissue. Its future clinical applications include automated risk stratification of T1 bladder cancer patients based on depth of LP invasion.
METHODS: Our method uses transfer learning in conjunction with convolutional neural networks (CNN) to identify different bladder layers from H&E images of bladder biopsies. Transfer learning enables CNN to equip computers with an ability to recognize and apply relevant knowledge from previous learning experiences when they encounter new tasks. Our proposed method is trained, cross-validated, and tested on 50,000 non-overlapping regions of size 64x64 pixels captured at 10x magnification. These regions are labeled for U, LP, MP, red blood cells (RBCs), inflammation (I), and cautery artifacts (C) by a GU pathologist. Each test image is processed by the CNN, producing six confidence heatmaps for each label. The MP and U maps are converted to binary masks, which represent the position of their respective bladder feature with ones and everything else with zeros. Depth of LP invasion is measured by determining the shortest distance from a given tumor nuclei in LP to the closest pixel with value 1 of the U binary mask.
RESULTS: The proposed method has 93.0% agreement with the pathologist in identification of bladder layers when tested on images of bladder cancer biopsies acquired from 86 patients. Additionally, given a set of tumor nuclei within LP, it precisely and accurately determines the depth of LP invasion, opening up the potential to sub stage T1 bladder cancer. When trained on samples from only three classes (U, LP, and MP), the method confuses I for U, RBCs for MP, and C for U, LP, and MP 90.0% of the times. This effect disappears in a six class method, thus a six class method is desirable.
CONCLUSIONS: Through accurate, automated segmentation of bladder layers from images of H&E biopsies and a given set of tumor nuclei, the depth of LP invasion can be quantified, allowing pathologists to make more informed, expedited, and accurate diagnoses of T1 bladder cancer. The mechanistic target of rapamycin (mTOR) has been implicated in driving tumor biology in multiple malignancies, including urothelial carcinoma (UC). We investigate how mTOR and phosphorylated mTOR (pmTOR) protein expression in both the tumor, and the tumor microenvironment, correlate with final pathologic stage at cystectomy after neoadjuvant chemotherapy (NAC).
METHODS: A single-institution retrospective analysis was performed on 62 patients with cT2-4Nany UC undergoing NAC followed by radical cystectomy. Diagnostic (transurethral resection specimens, TURBT) and post-chemotherapy radical cystectomy specimens were evaluated for mTOR and pmTOR protein expression using immunohistochemistry of the tumor, peritumoral stroma, and normal surrounding tissue. Protein expression levels were compared between TURBT and cystectomy samples. Whole transcriptome analysis was performed to evaluate mRNA expression relative to mTOR pathway activation.
RESULTS: Baseline levels of mTOR and pmTOR within TURBT specimens were not associated with clinical stage or response to chemotherapy overall. Non-responder patients, defined as pT2-T4/ pTanyNþ, had significantly elevated mTOR tumor staining (p¼0.006) and a sustained mTOR and pmTOR staining in the peritumoral and surrounding normal stroma (NS) of cystectomy specimens compared with baseline TURBT samples. In contrast, complete responders (pT0), had significant decreases in tumoral mTOR and pmTOR protein expression at cystectomy (p¼0.01-0.03). Several genes relevant to mTOR activity were found to be overexpressed (relative to TURBT) in the post-NAC cystectomy samples of non-responders (THBS1, FN1, FOS, CNN1, COL1A2).
CONCLUSIONS: Our results suggest that mTOR pathway activity is increased in the tumor and sustained the tumor microenvironment of patients with adverse pathologic findings at cystectomy after NAC. These findings suggest the relevance of targeting the mTOR pathway in bladder cancer.
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MP58-08 CANCER-ASSOCIATED FIBROBLASTS SECRETED EXOSOMAL MIR-146A PROMOTES BLADDER CANCER CHEMORESISTANCE
Junlong Zhuang*, Lan Shen, Jun Yan, Hongqian Guo, Nanjing, China, People's Republic of INTRODUCTION AND OBJECTIVES: Urinary bladder cancer (UBC) patients at muscle invasive stage have poor clinical outcome, due to high propensity for chemoresistance. Cancer-associated fibroblasts (CAFs), one of the principal constituents of the tumor stroma, play an important role in tumor development. Exosomal microRNAs (miRNAs) are emerging mediators of cancer-host crosstalk with other cells around. However, it is unclear whether CAFs from UBC promote cancer chemoresistance through exosomal miRNAs.
METHODS: We obtained human bladder cancer specimens and adjacent normal tissues from Nanjing Drum Tower Hospital. The bladder cancer specimen used for isolation of stromal fibroblasts was diagnosed as muscle invasive bladder cancer with histological grade II. Bladder cancer cells (T24 and 5637) were treated with the conditional medium (CM) or exosomes from normal fibroblasts (NFs) and CAFs, as well as an equal volume of complete culture medium. Exosomes were isolated from NF-CM or CAF-CM using ultracentrifugation or Total Exosome Isolation kit. T24 cells and NFs or CAFs in 0.1 ml 50% Matrigel were injected subcutaneously into the right flank of male athymic nude mice. Gemcitabine (40 mg/kg body weight) and cisplatin (6 mg/kg body weight) were respectively given on day 1, 5, 8 ,11 and day 2 via intraperitoneal injection. Tumor diameters were measured with calipers every 3 days and tumor volumes were calculated. The log-rank t-test was used for survival analysis. P value less than 0.05 was considered statistically significant. RESULTS: We found that co-culture with UBC CAFs promoted T24 xenograft tumor stemness in vivo. Compared to NFs, CAF cells promotes bladder cancer cell stemness via secreted exosomes in vitro. We conducted microarray assay to identify exosomal miRNAs potentially secreted by UBC CAFs and found that Vol. 199, No. 4S, Supplement, Sunday, May 20, 2018 THE JOURNAL OF UROLOGY â e775
